everolimus

Italy

Drugs containing this active substance

  • AFINITOR

    It is an anticancer drug used to treat postmenopausal women with advanced breast cancer (when other treatments no longer work), advanced neuroendocrine tumors originating from the stomach, intestine, lung, or pancreas, and advanced renal cell carcinoma.

    Form: tablets

    Active substance Dosage
    everolimus -

    ATC: L01EG02

    Manufacturer: NOVARTIS EUROPHARM LIMITED

  • It is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver. It is taken together with other medicines such as cyclosporine, tacrolimus, or corticosteroids.

    Form: tablets

    Active substance Dosage
    everolimus -

    ATC: L04AH02

    Manufacturer: NOVARTIS FARMA S.P.A.

  • It is an anticancer drug that reduces the blood supply to the tumor and slows the growth and spread of cancer cells. It is used to treat advanced breast cancer in postmenopausal women, advanced neuroendocrine tumors (stomach, intestine, lung, or pancreas), and advanced kidney cancer.

    Form: tablets

    Active substance Dosage
    everolimus -

    ATC: L01XE10

    Manufacturer: biocon pharma malta i limited

  • It is an anticancer drug used to treat postmenopausal women with advanced breast cancer (with positive hormone receptor status) when other treatments are no longer effective. It is taken together with another medicine called exemestane.

    Form: tablets

    Active substance Dosage
    everolimus -

    ATC: L01EG02

    Manufacturer: ETHYPHARM

  • It is an anticancer drug used to treat postmenopausal women with advanced breast cancer (when other treatments are no longer effective), advanced neuroendocrine tumors originating from the stomach, intestine, lung, or pancreas, and advanced kidney cancer.

    Form: tablets

    Active substance Dosage
    everolimus -

    ATC: L01EG02

    Manufacturer: MEDAC PHARMA SRL

  • It is an anticancer medicinal product used to treat postmenopausal women with advanced breast cancer (when other treatments are no longer effective), advanced neuroendocrine tumors originating in the stomach, intestine, lung, or pancreas, and advanced renal cell carcinoma.

    Form: tablets

    Active substance Dosage
    everolimus -

    ATC: L01EG02

    Manufacturer: SANDOZ GMBH

  • This medicinal product contains everolimus, a substance authorized for the treatment of certain medical conditions.

    Form: tablets

    Active substance Dosage
    everolimus -

    ATC: L01EG02

    Manufacturer: TAMARANG S.A.

  • Votubia is an anticancer medicinal product used to reduce the size of certain tumors (renal angiomyolipomas and subependymal giant cell astrocytomas) caused by tuberous sclerosis. The dispersible tablet versions are also used for the treatment of focal seizures associated with tuberous sclerosis in adults and children.

    Form: tablets

    Active substance Dosage
    everolimus -

    ATC: L01EG02

    Manufacturer: NOVARTIS EUROPHARM LIMITED